CD163 and rheumatoid arthritis: The same analysis was performed for frequency and MFI of IL-6, showing that in CD14+HLA-DR+CCR2+ and CD14+CD163+CCR2−, RA-CVD+ subjects have expanded inflammatory subsets versus RA-CVD− and healthy controls (Figure 1C,E).